Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription Articles published in Nephrol Dial Transplant Retrieve available abstracts of 140 articles: HTML format

Single Articles

October 2025
1. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
   A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
   Nephrol Dial Transplant. 2025;40:2159-2168.
   PubMed     Abstract available
   
   
   
2. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
   CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
   Nephrol Dial Transplant. 2025;40:2104-2117.
   PubMed     Abstract available
   
   
   
3. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
   A novel system to continuously estimate intradialytic blood pressure in real time.
   Nephrol Dial Transplant. 2025;40:2074-2080.
   PubMed     Abstract available
   
   
   
4. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
   Obesity as a modifiable risk factor in patients with chronic kidney disease.
   Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
   Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
   Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. TIAN Z, Hillebrand UC, Casper J, Schmidt-Ott KM, et al
   Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared to men.
   Nephrol Dial Transplant. 2025 Oct 16:gfaf217. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. TEOH STY, Yap DYH, Tang CSO, Chan TM, et al
   Chronic Kidney Disease G3-5 in Lupus Nephritis - Prevalence, Progression, and Risk Factors.
   Nephrol Dial Transplant. 2025 Oct 3:gfaf201. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2025
8. CHUANG MH, Wang HY, Kan WC, Chien CC, et al
   Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.
   Nephrol Dial Transplant. 2025;40:1897-1905.
   PubMed     Abstract available
   
   
   
9. ANDRE DE LA RAMBELJE M, Beldhuis IE, Heerspink HJL, Greasley PJ, et al
   Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.
   Nephrol Dial Transplant. 2025 Sep 8:gfaf180. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
10. SLON-ROBLERO MF, Stel VS, Sanchez-Alvarez E, Escola JM, et al
    Trends in Home Dialysis Over the Last Decade in Europe: an ERA Registry Study.
    Nephrol Dial Transplant. 2025 Aug 29:gfaf171. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. ATIQUZZAMAN M, Er L, Djurdjev O, Zheng Y, et al
    COVID-19 infection and the progression of kidney disease in British Columbia, Canada.
    Nephrol Dial Transplant. 2025;40:1717-1726.
    PubMed     Abstract available
    
    
    
12. CASINO FG, Casino A, Herva ET, Basile C, et al
    New formulas for calculating dialysis dose in incremental haemodialysis.
    Nephrol Dial Transplant. 2025 Aug 7:gfaf147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. BATTAGLIA Y, Shroff R, Meijers B, Nistor I, et al
    Haemodiafiltration versus high-flux haemodialysis-a Consensus Statement from the EuDial Working Group of the ERA.
    Nephrol Dial Transplant. 2025;40:1590-1614.
    PubMed     Abstract available
    
    
    
14. YAO YX, Tang C, Shi SF, Chen P, et al
    Red blood cell casts on kidney biopsy and progression of IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:1570-1579.
    PubMed     Abstract available
    
    
    
15. YOSHIDA M, Maeoka Y, Takahashi A, Ishiuchi N, et al
    Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis.
    Nephrol Dial Transplant. 2025;40:1538-1549.
    PubMed     Abstract available
    
    
    
16. PAGNIEZ MS, Fages V, Gatinois C, Larrue R, et al
    Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
    Nephrol Dial Transplant. 2025;40:1522-1530.
    PubMed     Abstract available
    
    
    July 2025
17. PERIS-FERNANDEZ M, Roca-Marugan MI, Viejo-Boyano I, Soldevila-Orient A, et al
    Hemodialysis removes protective metabolites and disrupts mitochondrial function.
    Nephrol Dial Transplant. 2025 Jul 31:gfaf145. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. ZOCCALI C, Chinnappa S, Fernandez-Fernandez B, Iatridi F, et al
    Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.
    Nephrol Dial Transplant. 2025 Jul 30:gfaf142. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. AOUN M, Combe C, Jadoul M
    Life Support in Hemodialysis Emergencies - Treatment standard.
    Nephrol Dial Transplant. 2025 Jul 15:gfaf136. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. BONIFANT G, Davis SN, Weir MR
    Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf083. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. LAVILLE SM, Mouheb A, Massy ZA, Jacquelinet C, et al
    Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf125. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. GUERRA JMA, Martinez-Martinez JI
    Multifactorial chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf122. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. CHERNEY DZI, Belmar N, Bjornstad P, Chacko MM, et al
    Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 3:gfaf114. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
24. MARENGO M, Migliori M, Merlotti G, Naso E, et al
    High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.
    Nephrol Dial Transplant. 2025 Jun 6:gfaf101. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. 
    Correction to: Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jun 5:gfaf099. doi: 10.1093.
    PubMed    
    
    
    
26. HALBRITTER J, Figueres L, Van Eerde AM, Capasso G, et al
    Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
    Nephrol Dial Transplant. 2025 Jun 3:gfaf092. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
27. WANG Z, Xiang W, Wang Y, Yu J, et al
    Patients with membranous lupus nephritis form two clusters with different prognoses.
    Nephrol Dial Transplant. 2025;40:1213-1224.
    PubMed     Abstract available
    
    
    
28. SHEN X, Chen P, Liu M, Liu L, et al
    Long-term outcomes of IgA nephropathy in China.
    Nephrol Dial Transplant. 2025;40:1137-1146.
    PubMed     Abstract available
    
    
    
29. MORALES E, Martin WP, Bevc S, Jenssen TG, et al
    How to individualise renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.
    Nephrol Dial Transplant. 2025 May 13:gfaf069. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. ZOCCALI C, Lameire N, Ronco C, Carlson N, et al
    Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives.
    Nephrol Dial Transplant. 2025 May 12:gfaf090. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. GLASSOCK RJ, Rule AD, Denic A, Delanaye P, et al
    KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective.
    Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093.
    PubMed    
    
    
    
32. 
    Correction to: Global health inequalities of chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2025 May 6:gfaf080. doi: 10.1093.
    PubMed    
    
    
    April 2025
33. QUENNEPOIX M, Koppe L, Bevier A, Barba C, et al
    Comparison of different heparin-free dialysis methods.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf082. doi: 10.1093.
    PubMed    
    
    
    
34. SCHMIDT-LAUBER C, Thompson C, Schmidt EA, Klopp A, et al
    Prevalence and Characteristics of Chronic Kidney Disease in the Hamburg City Health Study.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf075. doi: 10.1093.
    PubMed    
    
    
    
35. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    PubMed     Abstract available
    
    
    
36. YEPES-CALDERON M, Martin Del Campo Sanchez F, Kremer D, Knobbe TJ, et al
    Plasma Trimethylamine N-oxide Concentration and All-Cause Mortality in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 24:gfaf071. doi: 10.1093.
    PubMed     Abstract available
    
    
    
37. DOLAN KJ, Gist KM, Basalely A, Bottari G, et al
    Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry.
    Nephrol Dial Transplant. 2025 Apr 21:gfaf067. doi: 10.1093.
    PubMed     Abstract available
    
    
    
38. KANBAY M, Abdel-Rahman SM, Brinza C, Ozbek L, et al
    A Meta-analysis of Graft Survival, Patient Survival, and Delayed Graft Function in First-Time and Repeat Kidney Transplants.
    Nephrol Dial Transplant. 2025 Apr 15:gfaf066. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. MONTEZ DE SOUSA IR, Bonthuis M, Kramer A, Ordonez FA, et al
    Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
    Nephrol Dial Transplant. 2025;40:707-719.
    PubMed     Abstract available
    
    
    March 2025
40. AGRAWAL R, Waller JL, Baer SL, Bollag WB, et al
    Psoriaisis associates with increased risk for kidney transplant rejection.
    Nephrol Dial Transplant. 2025 Mar 26:gfaf047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. ZHAO Y, Yang K, Nguyen CM, Wu H, et al
    Sex-specific cardiac dysfunction in mice with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 21:gfaf056. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. FERRO CJ, Wanner C, Luyckx V, Stevens K, et al
    ABCDE to identify and prevent chronic kidney disease: a call to action.
    Nephrol Dial Transplant. 2025 Mar 19:gfaf057. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. ANDRADE A, Bachmann M, Bobot M, Bruchfeld A, et al
    Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
44. PEPIN M, Giannakou K, Levassort H, Farinha A, et al
    Care pathways for patients with cognitive impairment and chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
45. ZHANG Y, Ye Z, Zhang Y, Yang S, et al
    Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf052. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. BAKKER WM, Heerspink HJL, Berger SP, Wanner C, et al
    Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf046. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
47. URO-COSTE C, Lambert C, Audard V, Couzi L, et al
    Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
    Nephrol Dial Transplant. 2025;40:475-483.
    PubMed     Abstract available
    
    
    
48. PREKA E, Bonthuis M, Marks SD, Kramer A, et al
    Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry.
    Nephrol Dial Transplant. 2025 Feb 12:gfaf025. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. KANDURI SR, Badari A, Ullah F, Yang CW, et al
    Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf028. doi: 10.1093.
    PubMed    
    
    
    
50. XU H, Eriksdotter M, Hafez G, Mitra S, et al
    Cholinergic system in patients with chronic kidney disease: cognitive and renal implications.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf029. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
    COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf022. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. WAGNER CA
    Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
53. ALICIC RZ, Neumiller JJ, Tuttle KR
    Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
54. NEUEN BL, Yeung EK, Rangaswami J, Vaduganathan M, et al
    Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
55. ZHU D, Judge PK, Staplin N, Haynes R, et al
    Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
56. NARDONE M, Yau K, Kugathasan L, Odutayo A, et al
    Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
57. MOEDT E, Wasehuus VS, Heerspink HJL
    Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
    Nephrol Dial Transplant. 2025;40.
    PubMed     Abstract available
    
    
    
58. CHEIKH HASSAN H, Tunnicliffe DJ, Loyd L, Mullan A, et al
    Kidney failure from kidney stones: an ANZDATA study.
    Nephrol Dial Transplant. 2025;40:320-328.
    PubMed     Abstract available
    
    
    January 2025
59. JORGENSEN HS, Vervloet M, Cavalier E, Bacchetta J, et al
    The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.
    Nephrol Dial Transplant. 2025 Jan 28:gfae293. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. TORINO C, Mallamaci F, Tripepi R, Mezzatesta S, et al
    The use of lung-ultrasound monitoring and the risk of intradialysis hypotension in hemodialysis patients: an analysis in the context of a randomized clinical trial.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf015. doi: 10.1093.
    PubMed    
    
    
    
61. ZOCCALI C, Mallamaci F, Kanbay M, Tuttle KR, et al
    The Autonomic Nervous System and Inflammation in Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. YEN FS, Wei JC, Cheng WY, Huang CT, et al
    Low birth weight and chronic kidney disease with progression to kidney failure in children.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf018. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
63. FRIEDRICH J, Bellmann M, Klank D, Porubsky S, et al
    Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.
    Nephrol Dial Transplant. 2024;40:182-192.
    PubMed     Abstract available
    
    
    
64. BUTZ E, Schultheiss UT, Sekula P
    Modeling heterogeneity in the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Dec 19:gfae288. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. GANSEVOORT RT, Wheeler DC, Deben FM, Speeckaert M, et al
    The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
    Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
66. AKIFOVA A, Budde K, Amann K, Buettner-Herold M, et al
    Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
    Nephrol Dial Transplant. 2024 Nov 29:gfae282. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. HAHN LUNDSTROM U, Ramspek CL, Dekker FW, van Diepen M, et al
    Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
    Nephrol Dial Transplant. 2024;39:2079-2087.
    PubMed     Abstract available
    
    
    
68. SUENAGA T, Tanaka S, Kitamura H, Tsuruya K, et al
    Estimated potassium intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 27:gfae277. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. DASGUPTA I, Meadowcroft AM, Bhatt PR, Acharya A, et al
    Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2024 Nov 21:gfae273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. DIETER RA, Mattoo A, Hotchkis P, Jaffe IS, et al
    Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantation.
    Nephrol Dial Transplant. 2024 Nov 20:gfae271. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. DE HAAN A, Eijgelsheim M, Vogt L, Hoorn EJ, et al
    Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
    Nephrol Dial Transplant. 2024 Nov 19:gfae270. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. JOO YS, Yun HR, Kim HW, Koh HB, et al
    Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 15:gfae268. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. JUDGE PK, Tuttle KR, Staplin N, Hauske SJ, et al
    The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. METSARINNE K, Bodegard J, Toppila I, Uusi-Rauva K, et al
    Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022.
    Nephrol Dial Transplant. 2024 Nov 7:gfae242. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
    Noncanonical microglial IL-1beta maturation in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 4:gfae239. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
76. KRAMER A, Jager KJ, Chesnaye NC, Kerschbaum J, et al
    Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.
    Nephrol Dial Transplant. 2024;39:1835-1845.
    PubMed     Abstract available
    
    
    
77. NG MSY, Jones AT, Mallett AJ, O'Shaughnessy MM, et al
    Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014.
    Nephrol Dial Transplant. 2024;39:1846-1855.
    PubMed     Abstract available
    
    
    
78. HAMROUN A, Aymes E, Couchoud C, Bechade C, et al
    Elderly predialysis care pathways and early morbidity-mortality upon start of dialysis.
    Nephrol Dial Transplant. 2024 Oct 18:gfae236. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. DUARTE MP, Nobrega OT, Vogt BP, Pereira MS, et al
    Reference Values for Handgrip Strength, Five Times Sit-to-stand, and Gait Speed in Patients on Hemodialysis.
    Nephrol Dial Transplant. 2024 Oct 16:gfae232. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. COHEN EP, Denic A, Aperna F, Mullan AF, et al
    Stenosis of the glomerulotubular neck in progressive chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 16:gfae234. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. WAGNER CA, Massy ZA, Capasso G, Mattace-Raso F, et al
    Translational research on cognitive impairment in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 14:gfae229. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. ARDAVANI A, Curtis F, Hopwood E, Highton P, et al
    Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2024 Oct 9:gfae221. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. AN S, Qian H, Yang J, Han C, et al
    Cardiac magnetic resonance assessment of cardiac function across chronic kidney disease stages.
    Nephrol Dial Transplant. 2024 Oct 4:gfae222. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
84. BAE S, Chen Y, Sandal S, Lentine KL, et al
    Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
    Nephrol Dial Transplant. 2024 Sep 30:gfae218. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. ZHUANG B, Gan L, Liu B, Yuan W, et al
    Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2024;39:1649-1661.
    PubMed     Abstract available
    
    
    
86. STEL VS, Boenink R, Astley ME, Boerstra BA, et al
    A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.
    Nephrol Dial Transplant. 2024;39:1593-1603.
    PubMed     Abstract available
    
    
    
87. OLIVERAS L, Rosales BM, De La Mata N, Vajdic CM, et al
    Relative survival in patients with cancer and kidney failure.
    Nephrol Dial Transplant. 2024;39:1604-1612.
    PubMed     Abstract available
    
    
    
88. IATRIDI F, Carrero JJ, Gall EC, Kanbay M, et al
    A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
    Nephrol Dial Transplant. 2024 Sep 19:gfae209. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. MAYNE KJ, Sardell RJ, Staplin N, Judge PK, et al
    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Sep 14:gfae203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
90. MAHBOOBI S, Mollard R, Tangri N, Askin N, et al
    Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2024 Sep 14:gfae200. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. ARANA C, Hermida E, Rovira J, Caro JL, et al
    Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Sep 10:gfae186. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Proactively boosting home dialysis adoption in Europe.
    Nephrol Dial Transplant. 2024 Sep 9:gfae199. doi: 10.1093.
    PubMed    
    
    
    
93. CHO Y, Cullis B, Ethier I, Htay H, et al
    Global structures, practices, and tools for provision of chronic peritoneal dialysis.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    
94. HTAY H, Cho Y, Jha V, See E, et al
    Global structures, practices, and tools for provision of hemodialysis.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    
95. VIECELLI AK, Gately R, Barday Z, Shojai S, et al
    Worldwide organization and structures for kidney transplantation services.
    Nephrol Dial Transplant. 2024;39.
    PubMed     Abstract available
    
    
    August 2024
96. ZHANG LY, Dinh A, Johansen KL, McCulloch CE, et al
    Access to kidney transplantation from dialysis facilities affiliated with a transplant center versus free-standing dialysis facilities in the US.
    Nephrol Dial Transplant. 2024 Aug 30:gfae194. doi: 10.1093.
    PubMed    
    
    
    
97. ALUND O, Unwin R, Challis B, Kalra PA, et al
    A note on performance metrics for the Kidney Failure Risk Equation.
    Nephrol Dial Transplant. 2024;39:1523-1525.
    PubMed    
    
    
    
98. SACHEZ-ALAMO B, Moi L, Bajema I, Berden A, et al
    Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2024;39:1483-1493.
    PubMed     Abstract available
    
    
    
99. QUIROGA B, Diez J
    The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.
    Nephrol Dial Transplant. 2024 Aug 30:gfae193. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. PANIAGUA R, Ramos A, Avila M, Ventura MD, et al
     Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial.
     Nephrol Dial Transplant. 2024 Aug 20:gfae188. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. SCHROPPEL B, Bettac L, Schulte-Kemna L, Kachele M, et al
     Placement of tunneled hemodialysis catheters - interventional standard.
     Nephrol Dial Transplant. 2024 Aug 16:gfae181. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. GROSS O, Boeckhaus J, Weber LT, Heerspink HJL, et al
     Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.
     Nephrol Dial Transplant. 2024 Aug 9:gfae180. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2024
103. DONG Y, Wang Z, Guo W, Zhu L, et al
     Association between urinary C4d levels and disease progression in IgA nephropathy.
     Nephrol Dial Transplant. 2024;39:1279-1287.
     PubMed     Abstract available
     
     
     
104. KOMMER A, Kostev K, Schleicher EM, Weinmann-Menke J, et al
     Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Jul 18:gfae135. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. LI Z, Chen S, Tan Y, Lv J, et al
     The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Jul 17:gfae172. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. MAKHLOUFI M, Cottinet PJ, Ranchin B, Dureuil B, et al
     Hemodialysis versus peritoneal dialysis in children: an eco-audit.
     Nephrol Dial Transplant. 2024 Jul 13:gfae159. doi: 10.1093.
     PubMed    
     
     
     
107. COLLISTER D, Pyne L, Bhasin AA, Smyth B, et al
     Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
     Nephrol Dial Transplant. 2024 Jul 10:gfae156. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. FAGUER S, Serre JE, Brusq C, Bongard V, et al
     A randomized crossover trial of regional anticoagulation modalities for intermittent hemodialysis.
     Nephrol Dial Transplant. 2024 Jul 8:gfae155. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. GHIMIRE A, Lloyd AM, Bello AK, Battistella M, et al
     Prescribing patterns and medications costs in patients on maintenance hemodialysis and peritoneal dialysis.
     Nephrol Dial Transplant. 2024 Jul 4:gfae154. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
110. BOGATAJ S, Roelands B, Pajek M, Pajek J, et al
     Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients.
     Nephrol Dial Transplant. 2024;39:1198-1200.
     PubMed    
     
     
     
111. KIM JE, Park J, Jang Y, Kang E, et al
     Oral phosphate binders and incident osteoporotic fracture in patients on dialysis.
     Nephrol Dial Transplant. 2024 Jun 17:gfae139. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. HEERSPINK HJL, Agarwal R, Bakris GL, Cherney DZI, et al
     Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
     Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2024
113. BATTAGLIA Y, Mantovani A, Shroff R, Alfano G, et al
     Online haemodiafiltration and all-cause mortality: how fragile are the results of the studies published so far?
     Nephrol Dial Transplant. 2024;39:1034-1036.
     PubMed    
     
     
     
114. LABRIOLA L, Crott R, Desmet C, Romain C, et al
     Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up.
     Nephrol Dial Transplant. 2024;39:1000-1007.
     PubMed     Abstract available
     
     
     
115. CORTE-IGLESIAS V, Saiz ML, Andrade-Lopez AC, Salazar N, et al
     Propionate and butyrate counteract renal damage and progression to chronic kidney disease.
     Nephrol Dial Transplant. 2024 May 24:gfae118. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. VANHOLDER R, Bach D, Davies S, Finne P, et al
     Unlocking the Untapped Potential: The Neglected Home Dialysis Assets in Europe.
     Nephrol Dial Transplant. 2024 May 16:gfae111. doi: 10.1093.
     PubMed    
     
     
     
117. KREMER D, Salamah S, Groothof D, Post A, et al
     Plasma Symmetric Dimethylarginine and Kidney Graft Function in Kidney Transplant Recipients.
     Nephrol Dial Transplant. 2024 May 15:gfae109. doi: 10.1093.
     PubMed    
     
     
     
118. MCEWAN P, Gabb PD, Davis JA, Sanchez JJG, et al
     The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
     Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093.
     PubMed     Abstract available
     
     
     
119. KRAMER A, Boenink R, Mercado Vergara CG, Bell S, et al
     Time trends in preemptive kidney transplantation in Europe: an era registry study.
     Nephrol Dial Transplant. 2024 May 9:gfae105. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. IATRIDI F, Malandris K, Ekart R, Xagas E, et al
     Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study.
     Nephrol Dial Transplant. 2024 May 6:gfae104. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2024
121. WOLFGRAM DF, Richerson WT, Murray AM, Schmit BD, et al
     Cognitive deficits associate with cerebral hypoxia during hemodialysis.
     Nephrol Dial Transplant. 2024 Apr 30:gfae101. doi: 10.1093.
     PubMed    
     
     
     
122. LEMOINE S, Akbari A, Brahm G, Dorie J, et al
     Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.
     Nephrol Dial Transplant. 2024 Apr 30:gfae070. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. KANBAY M, Basile C, Battaglia Y, Mantovani A, et al
     Shared decision making in elderly patients with kidney failure.
     Nephrol Dial Transplant. 2024;39:742-751.
     PubMed     Abstract available
     
     
     
124. LIAO YR, Tsai YC, Hsieh TH, Tsai MT, et al
     FHL2 in arterial medial calcification in chronic kidney disease.
     Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093.
     PubMed     Abstract available
     
     
     
125. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
     Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
     Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
     PubMed     Abstract available
     
     
     
126. ZHANG X, Wang G, Li M, Li Y, et al
     Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
     Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
     PubMed     Abstract available
     
     
     
127. 
     Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
     Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
     PubMed    
     
     
     
128. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
     Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
     Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2024
129. ELEFTHERIADIS G, Naik MG, Osmanodja B, Halleck F, et al
     Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients.
     Nephrol Dial Transplant. 2024 Mar 28:gfae076. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
     The safety of a low protein diet in older adults with advanced chronic kidney disease.
     Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
     PubMed     Abstract available
     
     
     
131. FORBES AK, Hinton W, Feher MD, Elson W, et al
     A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
     Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
     PubMed     Abstract available
     
     
     
132. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
     Physical exercise: a polypill against chronic kidney disease.
     Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. ZHAI S, Liu D, Liu H, Li W, et al
     Cold atmospheric plasma for chronic kidney disease-related skin disorders.
     Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
134. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
     Health-related quality of life and symptom burden in patients on haemodialysis.
     Nephrol Dial Transplant. 2024;39:436-444.
     PubMed     Abstract available
     
     
     
135. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
     A tool to predict the risk of lower extremity amputation in patients starting dialysis.
     Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
     Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
     PubMed     Abstract available
     
     
     
137. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
     Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
     Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
     PubMed    
     
     
     
138. ADOLI LK, Couchoud C, Chatelet V, Lobbedez T, et al
     Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.
     Nephrol Dial Transplant. 2024 Feb 21:gfae047. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2023
139. DE LA MATA NL, Khou V, Hedley JA, Kelly PJ, et al
     Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
     Nephrol Dial Transplant. 2023 Nov 28:gfad253. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. HARDING JL, Di M, Pastan SO, Doucet N, et al
     Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
     Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.